Invention Grant
- Patent Title: Quinazoline derivatives for the treatment of cancer diseases
-
Application No.: US12093321Application Date: 2006-11-09
-
Publication No.: US08404697B2Publication Date: 2013-03-26
- Inventor: Flavio Solca , Andree Amelsberg , Gerd Stehle , Jacobus C. A. Van Meel , Anke Baum
- Applicant: Flavio Solca , Andree Amelsberg , Gerd Stehle , Jacobus C. A. Van Meel , Anke Baum
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Priority: EP05110656 20051111
- International Application: PCT/EP2006/068313 WO 20061109
- International Announcement: WO2007/054550 WO 20070518
- Main IPC: A61K31/517
- IPC: A61K31/517
Abstract:
The present invention relates to the use of quinazolines of formula (I), wherein the groups Ra to Rd have the meanings given in the claims and specification, in cancer therapy.
Public/Granted literature
- US20090306044A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES Public/Granted day:2009-12-10
Information query
IPC分类:
